ArticleKidney international reports2024

Efficacy and Safety of Subcutaneous Rituximab in Idiopathic Nephrotic Syndrome.

Paolo Cravedi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.